Dr. Mohammad B. Anwer, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Years since graduation
- 39
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 426
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
FL license ME0071633
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Orlando Orlando, FL
- HCA Florida Poinciana Hospital Kissimmee, FL
Medical groups
- Osceola Surgical Associates LLC (36 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 426
- Services billed
- 1,168
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 460 | 323 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 143 | 139 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 127 | 127 |
| Biopsy of large bowel using a flexible endoscope | 123 | 123 |
| Established patient office or other outpatient visit, 20-29 minutes | 110 | 100 |
| New patient office or other outpatient visit, 45-59 minutes | 84 | 84 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 59 | 27 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 31 | 31 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | 18 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 16 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Kissimmee, FL | 511 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Kissimmee, FL | 352 |
| Lactulose Other prescribers in Kissimmee, FL | 276 |
| Famotidine Other prescribers in Kissimmee, FL | 145 |
| Dicyclomine Hcl Other prescribers in Kissimmee, FL | 102 |
| Hydrocortisone Other prescribers in Kissimmee, FL | 58 |
| Ondansetron Odt (ondansetron) Other prescribers in Kissimmee, FL | 55 |
| Mesalamine Other prescribers in Kissimmee, FL | 50 |
| Linzess (linaclotide) Other prescribers in Kissimmee, FL | 48 |
| Omeprazole Other prescribers in Kissimmee, FL | 45 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 11 payments worth $265 in total to this clinician.
| Phathom Pharmaceuticals, Inc. | $71.93 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $38.52 |
| Intercept Pharmaceuticals, Inc. | $30.14 |
| Celltrion USA Inc. | $28.08 |
| Enterra Medical, Inc. | $27.09 |
| Janssen Biotech, Inc. | $26.67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.17 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.29 |
| Food and Beverage | $265 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.